Chronic inflammation in the tumor microenvironment can lead to increased cytokine production (e.g., IL-6, TNF-α, IL-1β), which promotes both prostate cancer progression and the survival/proliferation of abnormal plasma cell clones in MGUS [29,30]. Here, IL6 is linked to prostate cancer.